-
公开(公告)号:US07605164B2
公开(公告)日:2009-10-20
申请号:US11353252
申请日:2006-02-14
申请人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
发明人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
IPC分类号: A61K31/497 , A61K31/381 , A61K31/4409 , A61K31/4406 , A61K31/4402 , A61K31/42 , A61P9/04 , C07D401/10 , C07D403/10 , C07D213/643 , C07D213/65 , C07D213/68 , C07D261/18 , C07D333/22
CPC分类号: C07D401/12 , A61K31/4412 , A61K31/444 , A61K31/513 , C07D213/65 , C07D261/18 , C07D333/38 , C07D409/12 , C07D413/12
摘要: Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
摘要翻译: 某些取代的苯甲酰胺衍生物选择性地调节心脏肌节,例如通过增强心肌肌球蛋白,并且可用于治疗包括充血性心力衰竭的收缩性心力衰竭。
-
公开(公告)号:US07053094B2
公开(公告)日:2006-05-30
申请号:US11040478
申请日:2005-01-20
申请人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
发明人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
IPC分类号: A61K31/4965 , A61K31/44 , A61K31/42 , A01N43/40 , A01N43/80
CPC分类号: C07D401/12 , A61K31/4412 , A61K31/444 , A61K31/513 , C07D213/65 , C07D261/18 , C07D333/38 , C07D409/12 , C07D413/12
摘要: Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
-
公开(公告)号:US06908923B2
公开(公告)日:2005-06-21
申请号:US10327219
申请日:2002-12-20
申请人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
发明人: Fady Malik , Adam Lewis Tomasi , Bainian Feng , Erica Anne Kraynack , Kathleen A. Elias , Pu-Ping Lu , Whitney Walter Smith , Xiangping Qian , David J. Morgans, Jr.
IPC分类号: C07D333/40 , A61K31/381 , A61K31/42 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/497 , A61P9/00 , A61P9/04 , C07D213/64 , C07D213/65 , C07D213/75 , C07D213/78 , C07D213/81 , C07D261/18 , C07D333/38 , C07D401/04 , C07D401/12 , C07D401/14 , C07D409/12 , C07D413/12 , A61K31/4965 , A01N43/40 , A01N43/80 , A61K31/44
CPC分类号: C07D401/12 , A61K31/4412 , A61K31/444 , A61K31/513 , C07D213/65 , C07D261/18 , C07D333/38 , C07D409/12 , C07D413/12
摘要: Certain substituted benzamide derivatives of Formula I: selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
摘要翻译: 某些取代的式I的苯甲酰胺衍生物:选择性调节心肌肉瘤,例如通过增强心肌肌球蛋白,并且可用于治疗包括充血性心力衰竭的收缩性心力衰竭。
-
公开(公告)号:US07399866B2
公开(公告)日:2008-07-15
申请号:US10541596
申请日:2004-01-14
申请人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, Jr.
发明人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, Jr.
IPC分类号: C07D211/68 , C07D401/04 , C07D401/14
CPC分类号: A61K31/44 , A61K31/17 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/40 , C07D207/12 , C07D211/42 , C07D213/65 , C07D213/70 , C07D213/75 , C07D217/04 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D498/04 , C07D513/04
摘要: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, are useful in the treatment of systolic heart failure including congestive heart failure.
摘要翻译: 某些取代的脲衍生物选择性调节心脏肌节,例如通过增强心肌肌球蛋白,可用于治疗包括充血性心力衰竭的收缩性心力衰竭。
-
公开(公告)号:US20090176307A1
公开(公告)日:2009-07-09
申请号:US12348786
申请日:2009-01-05
申请人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, JR.
发明人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, JR.
IPC分类号: C12N5/08
CPC分类号: A61K31/44 , A61K31/17 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/40 , C07D207/12 , C07D211/42 , C07D213/65 , C07D213/70 , C07D213/75 , C07D217/04 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D498/04 , C07D513/04
摘要: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
-
公开(公告)号:US07491826B2
公开(公告)日:2009-02-17
申请号:US10890829
申请日:2004-07-14
申请人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, Jr.
发明人: Bradley Paul Morgan , Kathleen A. Elias , Erica Anne Kraynack , Pu-Ping Lu , Fady Malik , Alex Muci , Xiangping Qian , Whitney Walter Smith , Todd Tochimoto , Adam Lewis Tomasi , David J. Morgans, Jr.
IPC分类号: C07D211/68 , C07D401/04 , C07D401/14
CPC分类号: A61K31/44 , A61K31/17 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/40 , C07D207/12 , C07D211/42 , C07D213/65 , C07D213/70 , C07D213/75 , C07D217/04 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D498/04 , C07D513/04
摘要: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
摘要翻译: 某些取代的脲衍生物选择性地调节心肌肉瘤,例如通过增强心肌肌球蛋白,并且可用于治疗包括充血性心力衰竭的收缩性心力衰竭。
-
-
-
-
-